108 Another retrospective study reported that in a population with T2DM and previously diagnosed MASLD/MASH, GLP-1RA is associated with a decreased incidence of hepatocellular carcinoma (HCC) and a reduced risk of hepatic decompensation events compared with other antidiabetic agents
Recognizing UTI symptoms while on semaglutide Early detection leads to faster treatment and fewer complications
Parkinsons disease: mechanisms and models
A method for functional network connectivity among spatially independent resting-state components in schizophrenia
Pipeline and Technology Innovation Analysis GLP-1 Weight Loss Drug Market Pipeline: Triple Agonists, Oral Formulations, and Amylin Combinations Define the 20262035 Innovation Frontier Key GLP-1 Pipeline Molecules, Mechanisms, Development Stage, and Peak Sales Projections Triple agonist therapies targeting GLP-1, GIP, and glucagon receptors simultaneously represent the most significant efficacy advance in obesity pharmacotherapy since semaglutide
What we do not know We do not have randomized controlled trials comparing semaglutide alone versus semaglutide with methylcobalamin